22 Jun 2021

Increasing flexibility in pharmaceutical packaging for aseptic filling

PDF 1.2 MB

Highly complex biologics and other speciality drugs are representing an increasing proportion of the pharmaceutical market, and their pivotal role in this market has been challenging glass primary packaging producers year after year. Together with this, trends such as more personalized treatments in place of blockbuster drugs, increasing regulatory quality and compliance requirements, and a move towards more self-medication, are changing the way drugs are administered and therefore manufactured. Pharmaceutical companies are requested to be flexible, to reduce time-to-market, increasing quality and reducing costs. To meet the needs of the market and address these challenges, primary packaging design is moving towards ready-to-use (RTU) components as a preferred solution.

Content provided by our supplier

SGD Pharma

  • FR
  • 2015
    On CPHI since
  • 4
  • 1000 - 4999
Company types
Primary activities
Packaging materials

Other Content from SGD Pharma (2)